Hydroxyzine Hydrochloride Tablet, Film Coated
Product Images NDC 43063-960
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Hydrochloride (NDC 43063-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
43063960 Label (43063960)
This is a description of Hydroxyzine HCI tablets, USP 10mg, which should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions permitted between 15°C to 30°C (59° to B6°F). The tablets should be dispensed in a tight container as defined in the USP, with a child-resistant closure. The product comes in a package containing 100 tablets and is marketed and packaged by PD-Rx Pharmaceuticals, Inc. The tablets are manufactured by KVK-Tech, Inc. The lot number and expiration date are G20D82 and 04/2022, respectively. Detailed guidelines for usage should be checked from the package's outsert for full prescribing information.*
43063962 Label (43063962)
Hydroxyzine HCI tablets of 25mg, marketed and packaged by PD-Rx Pharmaceuticals, Inc. The package contains useful information about dosage, prescribing information, and storage requirements. It must be stored in a tightly closed container at a temperature range of 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The package also includes tamper-evident foil under the cap and warns to keep the medication out of children's reach. The tablet has a GTIN of 0343063962954, SNO of H19C450049, an expiry date of 11/2020, and is produced by KVK-Tech, Inc., Newtown, PA 18940.*
43063963 Label (43063963)
Hydroxyzine HCI is an active ingredient present in each tablet, containing 50mg. It is advised to refer the packaging outsert for complete prescribing information to follow the appropriate dose. The medicine must be stored in a tight container with a child-resistant closure and at a temperature range of 20° to 25°C (68° to 77°F) but with exceptions allowed between 15°C to 30°C (59° to 86°F) as per the USP Controlled Room Temperature. Precaution needs to be taken for avoiding the reach of the drug to kids. The drugs are tamper-evident through the foil seal under the cap, which requires to remain intact while buying. The package consists of 100 tablets of Hydroxyzine HCI. The medicine is packaged and marketed by PD-Rx Pharmaceuticals, Inc located in Oklahoma City, OK 73127, and manufactured by KVK-Tech, Inc of Newtown, PA 18940. Additionally, the package has a lot number Z9Z99 and an expiration date of 11/2020.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.